VBI (4170.TWO)
TWD 12.25
(-0.81%)
TWD 12.25
(-0.81%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 32.55 Million TWD | 4.2% |
| 2022 | 31.24 Million TWD | -21.76% |
| 2021 | 39.93 Million TWD | -45.46% |
| 2020 | 73.21 Million TWD | -14.02% |
| 2019 | 85.14 Million TWD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 9.69 Million TWD | 3.07% |
| 2024 Q1 | 9.4 Million TWD | 4.54% |
| 2023 Q4 | 9 Million TWD | 0.0% |
| 2023 Q2 | 4.3 Million TWD | 0.0% |
| 2023 FY | 32.55 Million TWD | 4.2% |
| 2023 Q1 | 4.3 Million TWD | -41.58% |
| 2023 Q3 | 9 Million TWD | 109.24% |
| 2022 Q3 | 7.36 Million TWD | 0.0% |
| 2022 FY | 31.24 Million TWD | -21.76% |
| 2022 Q4 | 7.36 Million TWD | 0.0% |
| 2021 FY | 39.93 Million TWD | -45.46% |
| 2020 FY | 73.21 Million TWD | -14.02% |
| 2019 FY | 85.14 Million TWD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 74.501% |
| Level Biotechnology Inc. | 151.99 Million TWD | 78.581% |
| Sagittarius Life Science Corp | 135.85 Million TWD | 76.037% |
| NeoCore Technology Co., Ltd. | 75.85 Million TWD | 57.085% |
| TaiMed Biologics Inc. | 225.23 Million TWD | 85.546% |
| GlycoNex Incorporation | 995 Thousand TWD | -3171.859% |
| GeneReach Biotechnology Corp. | 256.86 Million TWD | 87.326% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 83.235% |
| Visgeneer Inc. | 67.48 Million TWD | 51.758% |
| Mycenax Biotech Inc. | -375.19 Million TWD | 108.677% |
| Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 93.618% |
| G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 49.056% |
| Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 97.746% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | -10.912% |
| Enimmune corporation | 220.1 Million TWD | 85.209% |
| TaiRx, Inc. | 217.13 Million TWD | 85.007% |
| CHO Pharma, Inc. | 268.99 Million TWD | 87.898% |
| EirGenix Inc. | 236.74 Million TWD | 86.249% |
| BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 68.802% |
| Sunny Pharmtech Inc. | 357.62 Million TWD | 90.897% |
| Lin BioScience, Inc. | 1.09 Billion TWD | 97.032% |
| BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 87.769% |
| Feng Chi Biotech Corp. | 49.47 Million TWD | 34.194% |
| Bio Preventive Medicine Corp. | 1.08 Million TWD | -2906.002% |
| Lukas Biomedical Inc. | 177.45 Million TWD | 81.654% |
| RBC Bioscience Corporation | 58.35 Million TWD | 44.213% |
| BiOptic Inc. | 108.69 Million TWD | 70.048% |
| BRIM Biotechnology, Inc. | 90 Thousand TWD | -36072.222% |
| Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 53.057% |
| Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | -1144.933% |
| Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 94.944% |
| Anti-Microbial Savior BioteQ Co., Ltd | 329 Thousand TWD | -9795.137% |
| SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 29.264% |
| Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 72.85% |
| Neith Corporation | 66.87 Million TWD | 51.318% |
| Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 65.121% |
| NaviFUS Corp. | 11.82 Million TWD | -175.26% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 82.931% |
| Sinew Pharma Inc. | 186.25 Million TWD | 82.521% |
| Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 56.02% |
| Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 85.229% |
| Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 21.518% |
| AP Biosciences Inc | 32.25 Million TWD | -0.936% |
| Medigen Biotechnology Corp. | 1.85 Billion TWD | 98.241% |
| 3D Global Biotech Inc. | 5.27 Million TWD | -517.273% |
| Pharmosa Biopharm Inc. | 317.32 Million TWD | 89.741% |
| Intech Biopharm Corporation | -163.99 Million TWD | 119.851% |
| Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 97.117% |
| Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 21.52% |
| TWi Biotechnology, Inc. | 169.55 Million TWD | 80.8% |
| Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 77.857% |
| TCI GENE Inc. | 174.61 Million TWD | 81.356% |
| MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -180761.111% |
| Senhwa Biosciences, Inc. | 300.93 Million TWD | 89.182% |
| Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 88.811% |
| NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 61.219% |
| PharmaEngine, Inc. | 441.78 Million TWD | 92.631% |
| Savior Lifetec Corporation | 223.36 Million TWD | 85.425% |
| TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 87.42% |
| OBI Pharma, Inc. | 2.01 Billion TWD | 98.385% |
| Meribank Biotech Co., Ltd | 138.87 Million TWD | 76.557% |
| Acepodia, Inc. | 452.56 Million TWD | 92.807% |
| Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 93.982% |